Table 1 Anatomical (empirical) surgical staging for non-metastatic pancreatic cancer.
From: New implications from long-term outcomes of perioperative therapy in resectable pancreatic cancer
Resection Stage | Staging System | |
|---|---|---|
Alliance for Clinical Trials in Oncology—Alliance [31] | National Comprehensive Cancer Network—NCCN [19] | |
Superior Mesenteric Vein-Portal Vein | ||
Resectable | Interface between tumour and vessel measuring <180° | No tumour contact or ≤180° contact without vein contour irregularity |
Borderline Resectable | Interface between tumour and vessel measuring ≥ 180°, and/or reconstructablea occlusion | Solid tumour contact measuring >180°, or solid tumour contact ≤180° with contour irregularity or thrombosis |
Locally Advanced | Unreconstructable | Unreconstructable |
Superior Mesenteric Artery | ||
Resectable | No interface between tumour and vessel | No solid tumour contact |
Borderline Resectable | Interface between tumour and vessel measuring < 180° | Solid tumour contact ≤180° |
Locally Advanced | Interface between tumour and vessel measuring ≥ 180° | Solid tumour contact >180° |
Common Hepatic Artery or its First Order Branches | ||
Resectable | No interface between tumour and vessel | No solid tumour contact |
Borderline Resectable | Reconstructiblea, short-segment interface between tumour and vessel of any degree | Solid tumour contact without extension to coeliac or hepatic artery bifurcation |
Locally Advanced | Unreconstructable | Unreconstructable |
Coeliac Trunk | ||
Resectable | No interface between tumour and vessel | No solid tumour contact |
Borderline Resectable | Interface between tumour and vessel measuring < 180° | Solid tumour contact ≤180° |
Locally Advanced | Interface between tumour and vessel measuring ≥ 180° | Solid tumour contact >180° |
